Journal of Clinical Tuberculosis and Other Mycobacterial Diseases

Scope & Guideline

Exploring Innovations in Tuberculosis Research

Introduction

Delve into the academic richness of Journal of Clinical Tuberculosis and Other Mycobacterial Diseases with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN2405-5794
PublisherELSEVIER
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2015 to 2024
AbbreviationJ CLIN TUBER OTH MYC / J. Clin. Tuberc. Other Mycobacterial Dis.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The Journal of Clinical Tuberculosis and Other Mycobacterial Diseases focuses on advancing the understanding, diagnosis, treatment, and epidemiology of tuberculosis and other mycobacterial infections. It serves as a platform for disseminating research that addresses critical challenges in the management of these diseases.
  1. Epidemiology and Public Health:
    The journal emphasizes research on the epidemiology of tuberculosis and mycobacterial diseases, examining prevalence, risk factors, and public health implications across different populations and regions.
  2. Clinical Management and Treatment:
    It covers studies related to the clinical management of tuberculosis and other mycobacterial infections, including treatment regimens, drug resistance patterns, and the efficacy of novel therapies.
  3. Diagnostic Innovations:
    The journal highlights advancements in diagnostic methods for tuberculosis and mycobacterial diseases, focusing on novel technologies and methodologies that improve detection and monitoring.
  4. Co-Morbidities and Complications:
    Research addressing the interactions between tuberculosis and other health conditions, such as HIV, diabetes, and malnutrition, is a core focus, providing insights into managing patients with multiple health issues.
  5. Non-Tuberculous Mycobacterial Diseases:
    The journal includes studies on non-tuberculous mycobacterial infections, expanding the scope of research to encompass a broader range of mycobacterial diseases beyond tuberculosis.
Recent publications indicate a dynamic shift towards innovative themes and urgent public health challenges within the field of tuberculosis and mycobacterial diseases. These emerging trends reflect current global health priorities and research needs.
  1. Drug-Resistant Tuberculosis:
    The prevalence and management of multidrug-resistant tuberculosis (MDR-TB) has become a prominent focus, as researchers seek to address the growing challenge of drug resistance in various populations.
  2. Integrated Care Approaches:
    There is a rising interest in integrated care models that combine tuberculosis management with other health services, particularly in addressing co-morbid conditions such as HIV and diabetes.
  3. Digital Health Innovations:
    The use of digital health technologies, including telemedicine and mobile health applications, is gaining traction for improving tuberculosis management and adherence to treatment protocols.
  4. Socioeconomic and Behavioral Factors:
    Research examining the social determinants of health, including socioeconomic factors and patient behaviors, is increasingly featured, highlighting their impact on tuberculosis outcomes.
  5. Global Health Initiatives:
    Emerging themes include research related to global health initiatives, such as strategies to enhance tuberculosis screening, prevention, and treatment in low-resource settings.

Declining or Waning

While the journal maintains a broad focus, certain themes have shown a decline in publication frequency or relevance over recent years. This may reflect shifts in research priorities or emerging challenges in the field.
  1. Traditional Treatment Approaches:
    There is a noticeable decline in publications focusing on traditional treatment regimens for tuberculosis, as research increasingly shifts towards novel therapies and drug-resistant strains.
  2. Basic Laboratory Research:
    Research centered around basic laboratory studies of Mycobacterium species has decreased, possibly due to the growing emphasis on clinical and translational research that directly impacts patient care.
  3. Single-Country Studies:
    The prevalence of single-country studies has waned, with a trend towards multi-country studies or global perspectives that provide a more comprehensive understanding of tuberculosis and mycobacterial diseases.
  4. Historical Epidemiological Data:
    There seems to be a reduction in studies focusing on historical epidemiological data without addressing current implications, as the journal increasingly prioritizes contemporary research that informs current practices.

Similar Journals

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Transforming healthcare through impactful research.
Publisher: ELSEVIER TAIWANISSN: 1684-1182Frequency: 6 issues/year

Welcome to the Journal of Microbiology Immunology and Infection, a premier academic publication established in 1998 and now proudly owned by Elsevier Taiwan. As an Open Access journal since 2016, it provides unrestricted access to groundbreaking research in the fields of immunology, microbiology, and infectious diseases, making it an essential resource for researchers, practitioners, and students alike. The journal holds impressive rankings, including Q1 status in categories such as Infectious Diseases and Microbiology (medical), and a notable 92nd percentile in its Scopus ranking for Medicine - Infectious Diseases. With a dedicated focus on advancing knowledge and fostering collaboration within the scientific community, the Journal of Microbiology Immunology and Infection is committed to publishing high-impact research that significantly influences practice and policy in healthcare and life sciences. The journal is also recognized for its contribution to the ongoing dialogue surrounding contemporary issues in immunology and infection, positioning it as a vital platform for scholarly exchange and innovation.

International Journal of Mycobacteriology

Leading the charge in mycobacteriology research and treatment.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2212-5531Frequency: 4 issues/year

International Journal of Mycobacteriology is a peer-reviewed, open-access journal published by Wolters Kluwer Medknow Publications that specializes in the field of infectious diseases with a particular emphasis on mycobacterial research. Since its inception in 2012, this journal has emerged as a vital resource for researchers, healthcare professionals, and students aimed at advancing understanding and treatment of mycobacterial infections, including tuberculosis. With the journal being indexed in Scopus and holding a Q3 ranking in both Infectious Diseases and Microbiology (medical) for 2023, it reflects a substantial contribution to scholarly discourse in these domains, despite its current ranking positioning. Authors and readers benefit from the open access model, ensuring widespread dissemination of research findings and fostering collaboration across the global health community. Located in Mumbai, India, the journal continues to thrive with a commitment to quality research and innovation, welcoming contributions that further the exploration of mycobacteriology throughout the converged years from 2012 to 2024.

Revista Chilena de Infectologia

Connecting researchers to combat global health issues.
Publisher: SOC CHILENA INFECTOLOGIAISSN: 0716-1018Frequency: 6 issues/year

Revista Chilena de Infectologia is an esteemed academic journal dedicated to the field of infectious diseases and public health. Published by the SOC CHILENA INFECTOLOGIA, this journal has been pivotal in disseminating crucial research findings since its inception in 2000. While operating under ISSN 0716-1018 and E-ISSN 0717-6341, it aims to contribute to the understanding of both local and global health issues, particularly within the context of Chile. Currently, it holds a Q4 ranking in both the Infectious Diseases and Public Health, Environmental and Occupational Health categories as of 2023, reflecting its unique position among emerging voices in the field. The journal aspires to foster collaboration among researchers, professionals, and students by offering a platform for innovative studies and discussions that address pressing health challenges. Although it is not an Open Access journal, access options through institutional subscriptions are encouraged for a comprehensive review of its significant contributions to infectious disease research.

Egyptian Journal of Bronchology

Championing accessible research for respiratory innovation.
Publisher: SPRINGERISSN: 1687-8426Frequency: 4 issues/year

Egyptian Journal of Bronchology, published by SPRINGER, is a premier open access journal dedicated to advancing the field of respiratory medicine, particularly focusing on bronchial diseases and disorders. Since its establishment in 2013, this journal has provided a platform for the dissemination of high-quality research articles, systematic reviews, and clinical studies, making significant contributions to the understanding and management of bronchological conditions. With its commitment to open access, the journal ensures that research findings are readily available to a global audience, fostering knowledge exchange among researchers, healthcare professionals, and students alike. The Egyptian Journal of Bronchology serves as an essential resource in the field, reflecting a growing emphasis on accessible scientific knowledge and collaborative research in respiratory health.

Tuberculosis and Respiratory Diseases

Pioneering research for a healthier tomorrow.
Publisher: THE KOREAN ACAD TUBERCULOSIS & RESPIRATORY DISEASESISSN: 1738-3536Frequency: 4 issues/year

Tuberculosis and Respiratory Diseases is a leading open-access journal published by THE KOREAN ACADEMY OF TUBERCULOSIS & RESPIRATORY DISEASES, dedicated to disseminating knowledge in the fields of infectious diseases and pulmonary medicine. Since its inception in 1980, the journal has undergone significant growth, currently recognized in the elite Q2 category for both Infectious Diseases and Pulmonary and Respiratory Medicine as of 2023. With an impact factor reflecting its esteemed position—ranked 52nd in its category—it serves as a vital resource for researchers and healthcare professionals seeking cutting-edge insights, studies, and advancements in the management and treatment of respiratory diseases, particularly tuberculosis. The journal is committed to providing open access to its content since 2013, ensuring that critical research is available to scholars worldwide, fostering collaboration and innovation in the global fight against respiratory illnesses.

Infection and Drug Resistance

Transforming public health discourse on infectious diseases.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-6973Frequency: 1 issue/year

Infection and Drug Resistance, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to the critical fields of infectious diseases and pharmacology. Since its establishment in 2008, this journal has emerged as a vital resource for researchers, professionals, and students alike, offering thorough insights into the mechanisms of drug resistance and the effectiveness of various therapeutic interventions. With an impressive 2023 impact factor placing it in the Q2 category across multiple relevant disciplines, including Infectious Diseases and Pharmacology, it serves as a significant platform for high-quality research dissemination. Infection and Drug Resistance aims to foster a deeper understanding of the evolving challenges in managing infectious diseases and enhancing drug efficacy, contributing to the global discourse on public health. The journal's commitment to open access ensures that vital knowledge is readily available to promote broader scholarly engagement and innovation.

Archives of Clinical Infectious Diseases

Elevating Clinical Insights for a Healthier Tomorrow
Publisher: BRIEFLANDISSN: 2345-2641Frequency: 4 issues/year

Archives of Clinical Infectious Diseases is a peer-reviewed journal dedicated to advancing knowledge in the field of infectious diseases, published by BRIEFLAND in Iran. With a broad scope, it covers various aspects of cardiology, critical care, immunology, microbiology, public health, and toxicology, affirming its relevance in today's health landscape. Despite the lack of open access options, the journal maintains a strong reputation, reflected in its Q3 ranking in multiple categories within the 2023 category quartiles. The journal aims to provide a platform for researchers and practitioners to disseminate critical findings that can impact clinical practices and public health policies. Its commitment to rigorous peer review ensures that only high-quality research is published, thereby serving as an essential resource for professionals, students, and public health advocates. For those engaged in the ever-evolving world of infectious diseases, Archives of Clinical Infectious Diseases stands as a vital contribution to the medical literature.

INFECTION

Transforming Research into Real-World Solutions
Publisher: SPRINGER HEIDELBERGISSN: 0300-8126Frequency: 6 issues/year

INFECTION is a prestigious journal, published by Springer Heidelberg, that serves as a leading platform for the dissemination of critical research in the fields of Infectious Diseases, Microbiology, and Medicine. With an impressive Q1 ranking in multiple categories such as Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, the journal is recognized for its high-quality content and impactful contributions to the scientific community, as evidenced by its Scopus rankings placing it in the top 10th percentiles. Since its inception in 1973, and projected to continue until 2024, INFECTION has established itself as a vital resource for researchers, healthcare professionals, and students keen to explore the latest findings and advancements in infectious diseases. The journal provides a rigorous peer-review process, ensuring that only high-quality studies are published, making it an essential read for those seeking to deepen their understanding and stay abreast of the rapidly evolving landscape in infection research.

Brazilian Journal of Infectious Diseases

Unlocking the latest breakthroughs in infectious disease research.
Publisher: ELSEVIER BRAZILISSN: 1413-8670Frequency: 6 issues/year

The Brazilian Journal of Infectious Diseases, published by Elsevier Brazil, is a premier open-access journal dedicated to advancing research and clinical practice in the field of infectious diseases. Since its inception in 2001, this journal has been pivotal in disseminating innovative studies and reviews that inform healthcare professionals and researchers alike. With an impressive impact factor reflected by its ranking in the second quartile for Infectious Diseases and third quartile for Medical Microbiology in 2023, the journal ranks #127 out of 344 in medicine – infectious diseases and #61 out of 140 in medical microbiology, showcasing its reputable standing in the scientific community. The Brazilian Journal of Infectious Diseases invites contributions that highlight significant findings, novel methodologies, and critical reviews aimed at enhancing patient care and public health initiatives. With an international readership and a focus on pressing issues in infectious diseases, it serves as an essential platform for knowledge exchange and collaboration among scholars and practitioners across Brazil and beyond. By reinforcing the importance of open access to scientific literature, this journal not only promotes transparency but also enhances the global discourse surrounding infectious diseases.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Catalyzing change in global health through research.
Publisher: ELSEVIER SCI LTDISSN: 1201-9712Frequency: 12 issues/year

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, published by ELSEVIER SCI LTD, stands as a leading platform in the realm of infectious diseases, contributing significantly to the global understanding of this critical field. With an impressive impact factor, the journal maintains a distinguished Q1 ranking across various categories, including Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, demonstrating its high relevance and influence among contemporary research. Since its inception in 1996, it has embraced an Open Access model, allowing for wider dissemination of essential research findings that can inform public health policies and clinical practices. With a commitment to advancing scientific knowledge, this journal is not only a vital resource for researchers and professionals but also serves as an invaluable educational tool for students interested in the complexities of infectious diseases and their management. For those looking to stay at the forefront of research and innovation in this field, the INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES is an indispensable resource.